US2008044853A1PendingUtilityA1
Stably Maintained Multiple Copies of at Least Two Orf in the Same Orientation
Est. expiryJun 21, 2024(expired)· nominal 20-yr term from priority
C12N 2800/40C12N 2830/20C12N 15/67C12N 15/902C12N 9/52
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for constructing a host cell expressing a polypeptide of interest from at least two ORF's stably integrated onto the chromosome of the host cell comprising the steps of: a) providing the at least two ORF's encoding the same polypeptide, wherein the at least two DNA sequences of the ORF's differ in at least one position; b) integrating the at least two ORF's in the same orientation on the host cell chromosome.
Claims
exact text as granted — not AI-modified1 - 22 . (canceled)
23 . A method for constructing a host cell expressing a polypeptide of interest from at least two open reading frames stably integrated onto the chromosome of the host cell comprising the steps of:
a) providing the at least two open reading frames encoding the same polypeptide, wherein the at least two DNA sequences of the open reading frames differ in at least one position; b) integrating the at least two open reading frames in the same orientation on the host cell chromosome.
24 . The method of claim 23 , wherein the at least two open reading frames are integrated in the same location on the host cell chromosome.
25 . The method of claim 23 , wherein the open reading frames are transcribed as a polycistronic mRNA.
26 . The method of claim 23 , wherein segments of 100% sequence identity between the open reading frames are at the most 1000 bp.
27 . The method of claim 23 , wherein segments of 100% sequence identity between the open reading frames are at the most 80 bp.
28 . The method of claim 23 , wherein the open reading frames encode an enzyme.
29 . The method of claim 28 , wherein the enzyme comprises a protease.
30 . The method of claim 29 , wherein the protease is a serine protease.
31 . The method of claim 30 , wherein the serine protease is chosen from the group consisting of protease family S2A or S1E.
32 . The method of claim 31 , wherein the serine protease is encoded from a sequence chosen from the group consisting of Seq ID NO. 1, 2, or 51.
33 . A host cell comprising at least two open reading frames encoding the same polypeptide stably integrated in the same orientation onto the host cell chromosome wherein the at least two DNA sequences of the open reading frames differ in at least one position.
34 . The host cell of claim 33 , wherein the at least two open reading frames are integrated in the same location on the host cell chromosome.
35 . The host cell of claim 34 , wherein the open reading frames are transcribed as a polycistronic mRNA.
36 . The host cell of claim 33 , wherein segments of 100% sequence identity between the open reading frames are at the most 1000 bp.
37 . The host cell of claim 33 , wherein segments of 100% sequence identity between the open reading frames are at the most 80 bp.
38 . The host cell of claim 33 , wherein the open reading frames encode an enzyme.
39 . The host cell of claim 38 , wherein the enzyme comprises a protease.
40 . The host cell of claim 39 , wherein the protease is a serine protease.
41 . The host cell of claim 40 , wherein the serine protease is chosen from the group consisting of protease family S2A or S1E.
42 . The host cell of claim 41 , wherein the serine protease is encoded from a sequence chosen from the group consisting of Seq ID NO. 1, 2, or 51.
43 . A nucleic acid construct comprising at least two open reading frames encoding the same polypeptide in the same orientation, wherein the at least two DNA sequences of the open reading frames differ in at least one position.
44 . A method of producing the same polypeptide from at least two open reading frames stably integrated onto the host cell chromosome comprising the steps of:
i) culturing the host cell of claim 33 under conditions conducive for the expression of the polypeptide; and optionally ii) recovering the polypeptide.Join the waitlist — get patent alerts
Track US2008044853A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.